Williams Glen
Insider CIK 1559209 · GEVA SVP, Technical Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 20,002 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 33,750 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 13,334 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 25,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-22 | 2015-06-23 | 56 | $78.87 | $4.4K | 26,024 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 524 | — | $0 | 25,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-06-08 | 2015-06-09 | 833 | — | $0 | 20,002 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-06-08 | 2015-06-09 | 11,250 | — | $0 | 33,750 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-06-08 | 2015-06-09 | 833 | — | $0 | 13,334 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-06-08 | 2015-06-09 | 2,520 | $215.72 | $543.6K | 25,968 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-06-08 | 2015-06-09 | 833 | $57.56 | $47.9K | 27,634 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-06-08 | 2015-06-09 | 11,250 | $80.35 | $903.9K | 38,884 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-06-08 | 2015-06-09 | 10,396 | $214.72 | $2.23M | 28,488 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-06-08 | 2015-06-09 | 833 | $40.32 | $33.6K | 26,801 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-05 | 2015-06-09 | 25,500 | — | $0 | 25,968 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-05-06 | 2015-05-08 | 833 | — | $0 | 14,167 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-05-06 | 2015-05-08 | 833 | — | $0 | 20,835 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-05-06 | 2015-05-08 | 400 | $204.94 | $82.0K | 1,068 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-05-06 | 2015-05-08 | 666 | $203.99 | $135.9K | 1,468 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-05-06 | 2015-05-08 | 400 | $206.27 | $82.5K | 668 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-05-06 | 2015-05-08 | 100 | $206.97 | $20.7K | 568 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-05-06 | 2015-05-08 | 100 | $215.26 | $21.5K | 468 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-05-06 | 2015-05-08 | 833 | $40.32 | $33.6K | 1,301 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-05-06 | 2015-05-08 | 833 | $57.56 | $47.9K | 2,134 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-08 | 2015-04-09 | 15,263 | — | $0 | 21,668 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-08 | 2015-04-09 | 24,600 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-08 | 2015-04-09 | 39,863 | $96.08 | $3.83M | 468 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-08 | 2015-04-09 | 24,600 | $57.56 | $1.42M | 40,331 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-08 | 2015-04-09 | 15,263 | $40.32 | $615.4K | 15,731 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2015-04-07 | 2015-04-09 | 2,769 | — | $0 | 36,931 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2015-04-07 | 2015-04-09 | 2,769 | $40.32 | $111.6K | 3,237 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-04-07 | 2015-04-09 | 85 | $76.88 | $6.5K | 468 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2015-04-07 | 2015-04-09 | 2,769 | $96.04 | $265.9K | 468 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2014-06-30 | 2014-07-02 | 117 | $54.89 | $6.4K | 383 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-25 | 2014-06-26 | 300 | — | $0 | 39,700 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-25 | 2014-06-26 | 400 | — | $0 | 39,600 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-25 | 2014-06-26 | 400 | $57.56 | $23.0K | 966 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-25 | 2014-06-26 | 300 | $40.32 | $12.1K | 566 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-06-25 | 2014-06-26 | 700 | $108.02 | $75.6K | 266 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-12-31 | 2014-01-02 | 132 | $36.30 | $4.8K | 266 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-06-28 | 2013-07-01 | 134 | $35.68 | $4.8K | 134 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-10-04 | 2012-10-09 | 40,000 | — | $0 | 40,000 | SEC↗ |